China’s CXMT to favour domestic suppliers in US$5.2b memory-chip capacity push: source
ChangXin Memory Technologies (CXMT) plans to invest 34.9 billion yuan (US$5.2 billion) in expansion, with a substantial portion earmarked for domestic suppliers of chipmaking equipment, according to a source. The firm's stock filing on Monday detailed 24.1 billion yuan for a new technology R&D project and 10.8 billion yuan for a wafer testing base's second phase.
Equipment takes the largest share of CXMT’s new R&D project. Its filing puts purchases at nearly 22.4 billion yuan, about 93 percent of that project’s budget. Calling this simply a research investment would obscure how much depends on obtaining and putting machinery to work.
The wider 34.9 billion yuan plan also includes a wafer testing base expansion. These are related commitments, but they are not interchangeable: the amount assigned to equipment within R&D is not the equipment budget for the entire expansion. Keeping the categories separate helps explain what the announced figures actually establish.
SCMP attributes the preference for domestic equipment suppliers to a source. The filing supplies the spending figures; the source supplies the sourcing direction. Combining them into a claim that domestic vendors have already secured a particular amount of business would go beyond the reporting.
For equipment makers, the opportunity is clear enough without that leap. A large purchaser intends to expand and reportedly favours local supply. Which suppliers win, and how much usable capacity the spending produces, remain outcomes to establish rather than benefits already delivered.
Share this article
Related reading
6 stories
Alibaba touts “most powerful AI chip in China” for data center buildout
Alibaba's push for its own AI chip highlights China's broader drive for semiconductor self-sufficiency.

Sri Lanka’s Union Bank Upgrades Legacy Credit Card System With BPC

Huawei, Qualcomm strike multi-year patent agreement across 5G, AI

A Chatbot Almost Started a War With China. The Scariest Part Wasn’t the AI’s Mistake

OpenAI's Altman says AI benefits warrant accepting some risks

